Evidence map›Paper›PMID 34273406›Full record

ReviewFrontiers in neuroendocrinology2021

Brain to periphery in acute ischemic stroke: Mechanisms and clinical significance.

Pan Cui, Louise D McCullough, Junwei Hao

Open access · greenAbstract readReview
In one paragraph

Review in Frontiers in neuroendocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Migrasomes in Ischemic Stroke: Molecular Landscape and Pathophysiological Impact.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Modified human mesenchymal stromal/stem cells restore cortical excitability after focal ischemic stroke in rats.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Pan CuiDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Louise D McCulloughDepartment of Neurology, University of Texas Health Science Centre, Houston, TX 77030, USA.
Junwei HaoDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China. Electronic address: haojunwei@vip.163.com.
Capital Medical University · CN

Funding

Detrimental Effects of Age Related DysbiosisR01NS103592 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BRYAN, ROBERT M, MCCULLOUGH, LOUISE D. · 2018 to 2022
$3.2M
NINDS NIH HHS R01 NS103592
6 · The paper itself

Abstract

The social and public health burdens of ischemic stroke have been increasing worldwide. In addition to focal brain damage, acute ischemic stroke (AIS) provokes systemic abnormalities across peripheral organs. AIS profoundly alters the autonomic nervous system, hypothalamic-pituitary-adrenal axis, and immune system, which further yield deleterious organ-specific consequences. Poststroke systemic pathological alterations in turn considerably contribute to the progression of ischemic brain injury, which accounts for the substantial impact of systemic complications on stroke outcomes. This review provides a comprehensive and updated pathophysiological model elucidating the systemic effects of AIS. To address their clinical significance and inform stroke management, we also outline the resulting systemic complications at particular stages of AIS and highlight the mechanisms. Future therapeutic strategies should attempt to integrate the treatment of primary brain lesions with interventions for secondary systemic complications, and should be tailored to patient individualized characteristics to optimize stroke outcomes.

Indexed as

Brain IschemiaIschemic StrokeStrokeBrainHumansHypothalamo-Hypophyseal SystemPituitary-Adrenal SystemAcute ischemic strokeAutonomic dysfunctionHypothalamic-pituitary-adrenal axis activationStroke managementSystemic complicationsSystemic immune alterations

Identifiers

PMID34273406
PMCPMC9850260
OpenAlexW3180318043

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.